Reinventing the renin-angiotensin-aldosterone system based on experience from the COVID-19 pandemic

被引：0
作者：
Kurbel, Sven [1 ]
机构：
[1] Josip Juraj Strossmayer Univ Osijek, Med Fac, Osijek, Croatia
来源：
JOURNAL OF PHYSIOLOGY-LONDON | 2024年 / 602卷 / 20期
关键词：
ACE; ACE2; COVID-19; RAAS;
D O I：
10.1113/JP287202
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
[No abstract available]
引用
收藏
页码：5119 / 5124
页数：6
相关论文
共 50 条
[21]   Renin-Angiotensin-Aldosterone System Inhibitors and the Risk of AKI in COVID-19 Compared with Influenza [J].
Birkelo, Bethany C. ;
Parr, Sharidan K. ;
Perkins, Amy M. ;
Greevy Jr, Robert A. A. ;
Arroyo, Juan Pablo ;
Hung, Adriana M. ;
Vincz, Andrew J. ;
Shah, Shailja C. ;
Kapoor, Tarun ;
Matheny, Michael E. ;
Siew, Edward D. .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 17 (03) :423-425
[22]   Fallacies in medical practice: Renin-angiotensin-aldosterone system inhibition and COVID-19 as a Paradigm [J].
Triposkiadis, Filippos ;
Boudoulas, Konstantinos Dean ;
Xanthopoulos, Andrew ;
Boudoulas, Harisios .
HELLENIC JOURNAL OF CARDIOLOGY, 2021, 62 (03) :185-189
[23]   Renin-Angiotensin-Aldosterone System Inhibitors and COVID-19 Infection or Hospitalization: A Cohort Study [J].
Dublin, Sascha ;
Walker, Rod L. ;
Floyd, James S. ;
Shortreed, Susan M. ;
Fuller, Sharon ;
Albertson-Junkans, Ladia ;
Harrington, Laura B. ;
Greenwood-Hickman, Mikael Anne ;
Green, Beverly B. ;
Psaty, Bruce M. .
AMERICAN JOURNAL OF HYPERTENSION, 2021, 34 (04) :339-347
[24]   Activation of the renin-angiotensin-aldosterone system is associated with Acute Kidney Injury in COVID-19 [J].
Dudoignon, Emmanuel ;
Moreno, Nabila ;
Deniau, Benjamin ;
Coutrot, Maxime ;
Longer, Romain ;
Amiot, Quentin ;
Mebazaa, Alexandre ;
Pirracchio, Romain ;
Depret, Francois ;
Legrand, Matthieu .
ANAESTHESIA CRITICAL CARE & PAIN MEDICINE, 2020, 39 (04) :453-455
[25]   COVID-19 and renin angiotensin aldosterone system: Pathogenesis and therapy [J].
Babajani, Fatemeh ;
Kakavand, Atefeh ;
Mohammadi, Hossien ;
Sharifi, Armin ;
Zakeri, Saba ;
Asadi, Soheila ;
Afshar, Zeinab Mohseni ;
Rahimi, Zohreh ;
Sayad, Babak .
HEALTH SCIENCE REPORTS, 2021, 4 (04)
[26]   Renin-angiotensin-aldosterone system blockers in Bulgarian COVID-19 patients with or without chronic kidney disease [J].
Filev, Rumen ;
Rostaing, Lionel ;
Lyubomirova, Mila ;
Bogov, Boris ;
Kalinov, Krassimir ;
Svinarov, Dobrin .
MEDICINE, 2022, 101 (48) :E31988
[27]   Renin-Angiotensin-Aldosterone System Blockers Prior to Hospitalization and Their Association With Clinical Outcomes in Coronavirus Disease 2019 (COVID-19) [J].
Banwait, Ranjit ;
Singh, Devina ;
Blanco, Anamarys ;
Rastogi, Vaibhav ;
Abusaada, Khalid .
CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (02)
[28]   Risk of severe COVID-19 in hypertensive patients treated with renin-angiotensin-aldosterone system inhibitors [J].
Golpe, Rafael ;
Perez-de-Llano, Luis A. ;
Dacal, David ;
Guerrero-Sande, Hector ;
Pombo-Vide, Beatriz ;
Ventura-Valcarcel, Pablo .
MEDICINA CLINICA, 2020, 155 (11) :488-490
[29]   Should we continue to use renin-angiotensin-aldosterone system blockers in patients with COVID-19? [J].
Copur, Sidar ;
Kanbay, Asiye ;
Kanbay, Mehmet .
CLINICAL KIDNEY JOURNAL, 2022, 15 (05) :852-854
[30]   Is Spironolactone the Preferred Renin-Angiotensin-Aldosterone Inhibitor for Protection Against COVID-19? [J].
Wilcox, Christopher S. ;
Pitt, Bertram .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2021, 77 (03) :323-331
12345